Minireviews
Copyright ©The Author(s) 2019.
World J Gastroenterol. Jun 7, 2019; 25(21): 2581-2590
Published online Jun 7, 2019. doi: 10.3748/wjg.v25.i21.2581
Table 1 Depicts pre-clinical demographic and clinical data and post-operative changes to symptoms and gastric emptying
ArticleShlomovitz et al[25], 2014Gonzalez et al[26], 2017Kahaleh et al[27], 2018Rodriguez et al[28], 2017Rodriguez et al[29], 2018Malik et al[30], 2018Jacques et al[31], 2017Dacha et al[32], 2017Mekaroonkamol et al[33], 2018Khashab et al[34], 2017
n72933471001320163030
Female (%)10065.506678.7085.0053.5881.2586.7057
Age (mean)5152.85243.74545.744.764747
Previous gastric stim4 (13.8%)2 (6%)16 (34.0%)20 (20%)3 (23%)04 (25%)4 (13.3%)0
Previous botox treatment1 (3%)4 (12%)28 (59.6%)46 (46%)11 (84.6%)2 (10%)01 (3%)12 (40%)
Pre GES 4 h (mean %)2140 ± 344537.2 ± 25.139 ± 26.549 ± 245762.563.0 ± 25.537
Pre GCSI3.3 ± 0.94.613.8 ± 0.862.2 ± 0.83.53.413.5 ± 0.6
Gastroparesis: Idiopathic415122756445127
Gastroparesis: Diabetes077122111091211
Gastroparesis: Post-surgical2512819811512
Gastroparesis: Scleroderma0221000
Total of major postoperative complications4/75/291/330/4710/1001/133/200/1612/30
Post GES Residual 4 hours4%28 ± 4517% ± 1720.4 ± 26.116.3 ± 21.433 ± 281525.422.2 ± 20.517% ± 16
Symptom improvement85.70%69%86%73%90%81%76.70%86%
How defined improvementClinical improvementDecrease in GCSIClinical improvement1Not definedNot definedCPGAS scoreGCSI decrease by 0.75Decrease in GCSIDecrease in GCSI2Clinical improvement
Length of follow up (mo)6.5663333126-186
Timing of F/u GES in days8456909084845642-5681-105
GES improvement4/5 (90%)23/29 (79.3%)78% α4/6 (66.7%)19/20 (95%)12/12 (100%)78.3%α14/17, 82.3%
Normalization of GES0/516/294/657% α06/209/1247.8%α8/17